October 13, 2021
Mayo Clinic collaborates with Personalis Inc. to expand cancer genomic testing
By Susan Murphy
By Joe Dangor Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade comprehensive cancer genomic sequencing to cancer patients who choose to participate. Test results will be available to patients and their treating health care providers to guide therapeutic decisions, advance cancer research, and support the development of […]
Tags: cancer genomics, Dr. Konstantinos Lazaridis, Genetic Testing, Mayo Clinic Cancer Center
November 5, 2018
Pharmacogenomics: finding the right drug, dose for cancer therapy
By Sharon Rosen
Each year, nearly 300,000 patients receive the lifesaving chemotherapy 5-fluorouracil (5-FU) to treat many types of cancer, including colorectal, breast, bowel, skin, pancreatic, and esophageal cancer. While it can be an effective treatment, it doesn’t work for everyone. In fact, up to 30 percent of those who receive the standard dose can have serious, life-threatening […]
Tags: #5-fluorouracil, #5-FU chemotherapy, #chemotherapy side effects, #DPYD gene, #drug-gene interactions, #gene verifier model, breast cancer, chemotherapy, colorectal cancer, mayo clinic, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualized Medicine
June 19, 2018
Mayo Clinic discovers genetic links to pancreatic cancer
Pancreatic cancer is one of the most difficult forms of cancer to diagnose and treat. For many patients, the disease is not treatable through surgery and standard chemotherapy. New research published in JAMA, supported in part through the Mayo Clinic Center for Individualized Medicine, gives insight into the underlying genetic links to pancreatic cancer. Senior […]
Tags: #Dr. Fergus Couch, cancer genomics, Cancer Research, DNA Testing, Dr. Gloria Petersen, JAMA study, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualize Medicine, Mayo Clinic Department of Laboratory Medicine and Pathology, Pancreatic Cancer
March 15, 2017
By Sharon Rosen
Article by Colette Gallagher, Public Affairs Mayo Clinic researchers reported in the Journal of the National Cancer Institute the results of the Breast Cancer Genome-Guided Therapy (BEAUTY) study designed to help researchers and physicians better understand why current standard chemotherapy stops breast cancer in some women but fails in others. Tumor sequencing is increasingly used to select […]
Tags: #Breast Cancer Genome-Guided Therapy study, #DNA sequencing tests, #Journal of the National Cancer Institute, #tumor sequencing, breast cancer, center for individualized medicine, chemotherapy, Dr. Judy Boughey, Dr. Matthew Goetz, mayo clinic, Mayo Clinic Cancer Center, medical research
October 5, 2015
Genes of Colon Cancer Recurrence Differs Among Blacks, Whites and Asians
By Jeff Briggs
Excellent work in individualized medicine is being done throughout Mayo Clinic. The Mayo Clinic Cancer Center is one such place. A recent study shows that colon cancer recurrence and survival rates differs among races. The genetic makeup of colon cancer tumors varies among African-Americans, whites and Asians. Here is the report: * * * […]
Tags: cancer, center for individualized medicine, colon cancer, Dr. Frank Sinicrope, Dr. Harry Yoon, genetic, Genetic Testing, individualized medicine, Mayo Clinic Cancer Center